3StocksOnFire — US Stock Trading Community · 451+ trades · 257% returns · 15,000 members · Main Site · Trader's Guide · Articles · Video Analyses
3 Stocks On Fire
3StocksOnFire Community Forum
Home Message Boards Trader's Guide Articles Video Analysis About Us Search Register

News:

Welcome to 3StocksOnFire! US stock trading community (2005-2010) with 451+ documented trades and 15,000+ members. View Portfolios | Stock Articles | Quotes

Main Menu

NGEN.PK

Started by ours, May 20, 2005, 04:23:43 PM

Previous topic - Next topic

ours

Hi there,
take a look at Nanogen (NGEN), there is a nice move on the way
I already made 2 nice trades with the stock and I intend to buy some
next week.
Have a good weekend
Bernie

calven

Very nice find ! (applaud)   

Looks like a wedge is being tested for a breakout. We'll see what happens tomorrow...look promising for a runner!

>:D

StockGravity.com - The Forces that Move Stocks!
http://www.stockgravity.com

sebfr

What do you think about NGEN ? Me i believe a bearish signal is done...

poorman1

There's some pennant action forming with this one.  I haven't been in NGEN since 2004.  I agree, bottom in place.

Good luck!

kslifka

Add NGEN to your bird flu stock list. ;)

http://biz.yahoo.com/bw/061204/20061204006027.html?.v=1

Nanogen Wins CDC Contract to Develop Avian Flu Diagnostic
Monday December 4, 2:59 pm ET

SAN DIEGO--(BUSINESS WIRE)--Nanogen, Inc. (Nasdaq:NGEN - News), developer of advanced diagnostic products, announced today it has been awarded a $4.5 million contract from the U.S. Centers for Disease Control and Prevention (CDC) to develop a unique multi-analyte Point-Of-Care (POC) diagnostic assay for Influenza in support of the US Government's efforts to strengthen its readiness for a potential influenza pandemic. The goal of the development is to employ proprietary Nanogen technology in a low cost, high sensitivity POC immunoassay that simultaneously detects Influenza Type A, Type B, seasonal flu (H1N1 and H3N2) and avian flu (H5N1) in a simple to use assay format. This development program is partnered with HX Diagnostics, Inc., which will commercialize the product upon approval. The current award of $4.5 million funds the first two phases of a five-phase development project and, if all five phases are funded by the CDC, can total approximately $12.5 million over the next two to three years.

kslifka

Nano you like???

Well NGEN has held above the 200dma for the first time in a long time.  Will it hold tomorrow??

Well I feel safe holding this one.

Anyway...looks like it broke it's downtrend and looking for a reversal after the government contract for Bird Flu diagnostic grant.

REALDEALS21

UP 28% !!  ;D ON SOME BIG NEWS !

Press Release Source: Nanogen, Inc.


Nanogen Obtains GSA Contract for NanoChip(R) 400 Platform
Wednesday April 4, 8:00 am ET


SAN DIEGO--(BUSINESS WIRE)--Nanogen, Inc. (Nasdaq:NGEN - News), developer of advanced diagnostic products, announced today that it has obtained a United States Government Service Administration (GSA) Schedule contract. The contract, number GS-07F-0283T, applies to the company's NanoChip® 400 microarray instrument and reagents.

The contract enables Nanogen to be listed on an approved GSA Schedule and sell its NanoChip products directly to government agencies such as the National Institutes of Health (NIH), military hospitals and Veteran's Administration (VA) hospitals. Nanogen's inclusion as a GSA Schedule Vendor allows government customers to obtain approved pricing and license terms from a pre-qualified vendor. Government agencies typically have separate GSA and non-GSA budgets, and therefore inclusion as a GSA vendor allows Nanogen broader access to government customers' budgets.

"Securing a GSA Schedule contract for the NanoChip platform is a terrific opportunity for Nanogen, because both current and new customers will be able to expedite future purchases through the GSA ordering process," said David Ludvigson, Nanogen's president and chief operating officer. "Increased efficiency, coupled with the opportunity for immediate implementation, will be the result for customers in the government sector."

The NanoChip® 400 instrument is an automated multiplexing platform that laboratories use to detect genetic sequences. Tests can be performed using reagents supplied by Nanogen, or laboratories can develop a variety of "homebrew" assays. The NanoChip instrument employs Nanogen's core microarray technology, which utilizes patented microfluidics and electronic technology to automate sample handling and detection of results.

Founded in 1949, GSA serves as a centralized procurement and property management agency for the federal government. GSA manages more than one-fourth of the government's total procurement dollars and influences the management of $500 billion in federal assets. More information is available at https://www.gsaadvantage.gov.


setravis

Changed Ticker Symbol...
NGEN is no longer valid. It has changed to NGEN.PK
"Success loves to hide behind challenges.
Embrace the challenge, enjoy the journey."

Do your own DD and invest based on your DD, not mine !

Semper Fi
S.E.Travis

setravis

NGEN.PK - Momentum...

Nanogen, Inc., a diagnostics company, engages in developing, manufacturing, and selling diagnostic products for use in the in vitro diagnostic market in the United States, Canada, and Europe.

"Success loves to hide behind challenges.
Embrace the challenge, enjoy the journey."

Do your own DD and invest based on your DD, not mine !

Semper Fi
S.E.Travis